Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements^☆

References 

1. Food and Drug Administration . Guidance for Industry: Consumer-directed Broadcast Advertisements (Draft Guidance). Rockville, Md: Division of Drug Marketing, Advertising, and Communications (DDMAC); 1997;62 Federal Register at 43,171 July 1997
2. Food and Drug Administration . Guidance for Industry: Consumer-directed Broadcast Advertisements. Rockville, Md: Division of Drug Marketing, Advertising, and Communications (DDMAC); 1999;http:www.fda.gov/cder/guidance/index.htm
3. Schommer Jon C, Doucette William R. Consumer Preferences for and Retention of Information from Direct-to-Consumer Advertising. Presented at National Council on Patient Information and Education 12th National Conference, Washington, DC. May 13, 1999.
4. Slaughter E. An Assessment of Consumer Reaction to Direct-to-consumer Advertising. Presented at American Pharmaceutical Association 146th Annual Meeting, San Antonio, Tex, March 9, 1999.
5. Baylor-Henry . Regulation of prescription drug promotion: direct-to-consumer advertising. Clinical Therapeutics. 1998;20:C86–C95
   • Abstract
   • Full-Text PDF (725 KB)
   • CrossRef
6. Wilkes Michael S, Bell Robert A, Kravitz Richard L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs. 2000;19:110–128
7. Levy Sandra. DTC ads prompting mature consumers to visit the doctor. Drug Topics. 1999;143:21
8. Aikin Kathryn. Direct-to-consumer Advertising of Prescription Drugs: Preliminary Patient Survey Results. Rockville, Md: FDA, Division of Drug Marketing, Advertising and Communications; 2002;
9. FDA, Office of Medical Policy, Division of Drug Marketing, Advertising and Communications. Attitudes and Behaviors Associated with Direct-to-consumer (DTC) Promotion of Prescription Drugs: Main Survey Results. Rockville, Md: FDA; 1999;
10. Slaughter Ed. 5th Annual Survey: Consumer Reaction to DTC Advertising of Prescription Medicines, 2001-2002. Emmaus, Pa: Rodale, Inc; 2002;
11. Slaughter Ed, Schumacher Martha. Prevention's International Survey on Wellness and Consumer Reaction to DTC Advertising of Rx Drugs, 2000-2001. Emmaus, Pa: Rodale, Inc; 2001;
12. Prevention Magazine . Year Two: A National Survey of Consumer Reactions to Direct-to-consumer Advertising, 1999. Emmaus, Pa: Rodale, Inc; 1999;
13. Prevention Magazine . National Survey of Consumer Reactions to Direct-to-consumer Advertising, 1998. Emmaus, Pa: Rodale, Inc; 1998;
14. Prevention Magazine . Navigating the Medication Marketplace: How Consumers Choose, 1997. Emmaus, Pa: Rodale, Inc; 1997;
15. Henry J, Kaiser Family Foundation . Understanding the Effects of Direct-to-consumer Prescription Drug Advertising. Menlo Park, Calif: Henry J. Kaiser Family Foundation; 2001;
16. National Consumers League . Health Care Information and the Consumer: A Public Opinion Survey. Washington, DC: National Consumers League; 1998;
17. Foley Lisa, Gross David. Are Consumers Well Informed About Prescription Drugs? The Impact of Printed Direct-to-consumer Advertising. Washington, DC: AARP; 2000;
18. Weissman Joel S, Blumenthal David, Silk Alvin J, Zapert Kinga, Newman Michael, Leitman Robert. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs. 2003;W3-82–W3-95web exclusive
19. White Hugh J, Draves Lindsey P, Soong Roland, Moore Chris. Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market. International Journal of Advertising. 2004;23:53–68
20. Aikin Kathryn, Swasy John L, Braman Amie C. Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs – Summary of FDA Survey Research Results, Final Report, November 19, 2004. Rockville, Md: Food and Drug Administration, Center for Drug Evaluation and Research.
21. Chelimsky Eleanor. Prescription Drugs, Little is Known About the Effects of Direct-to-Consumer Advertising. General Accounting Office, Program Evaluation and Methodology Division, 91-19: Washington, DC; 1991.
22. Chelimsky Eleanor. Prescription Drugs, Selected Direct-to-Consumer Advertising Studies Have Methodological Flaws. General Accounting Office, Program Evaluation and Methodology Division, 91-20: Washington, DC; 1991.
23. Doucette William R, Schommer Jon C. Consumer preferences for drug information after direct-to-consumer advertising. Drug Information Journal. 1998;32:1081–1088
24. Glasgow Christina, Schommer Jon C, Gupta Kiran, Pierson Krista. Promotion of prescription drugs to consumers: case study results. Journal of Managed Care Pharmacy. 2002;8:512–518
25. Hollon M. Direct-to-consumer marketing of prescription drugs: creating consumer demand. Journal of the American Medical Association. 1999;281:382
26. Holmer A. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of the American Medical Association. 1999;281:380
27. Lyles Alan. Direct marketing of pharmaceuticals to consumers. Annual Reviews in Public Health. 2002;23:73–91
28. Reeves Kelly N. Direct-to-consumer broadcast advertising: empowering the consumer or manipulating a vulnerable population?. Food and Drug Law Journal. 1998;53:661–679
    • MEDLINE
29. Taylor Christine and Schommer Jon C. Consumer Opinions of Direct-to-consumer Prescription Drug Advertising. Presented to the Academy of Pharmacy Practice and Management, 145th Annual Meeting of the American Pharmaceutical Association, Miami Beach, Fla, March 22, 1998.
30. Wosinksa Marta. Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products, Working Paper No. 03–058. Boston, Mass: Harvard Business School; 2003;
31. Schommer Jon C, Doucette William R, Mehta Bella H. Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clinical Therapeutics. 1998;20:617–632
    • Abstract
    • Full-Text PDF (1135 KB)
    • CrossRef
32. Schommer Jon C., Doucette William R, Mehta Bella H. Manufacturer sponsored Web sites as an information source for consumers after viewing direct-to-consumer advertising for prescription drugs. Ecommerce Research Forum. 1999;1, http://www.ecommerce.mit.edu
33. Schommer Jon C, Doucette William R, Worley Marcia M. Processing prescription drug information under different conditions of presentation. Patient Education and Counseling. 2001;43:49–59
    • Abstract
    • Full Text
    • Full-Text PDF (103 KB)
    • CrossRef
34. Sullivan Donald L, Schommer Jon C, Birdwell Stephen W. Consumer retention of risk information from direct-to-consumer advertising. Drug Information Journal. 1999;33:281–290
    • CrossRef
35. Fishbein Martin, Jaccard James J, Davidson Andrew R, Ajzen Icek, Barbara Loken. Predicting and understanding family planning behaviors: beliefs, attitudes, and intentions. In:  Ajzen Icek,  Fishbein Martin editor. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980;
36. Food and Drug Administration . Attitudes and Behaviors Associated with Direct-to-Consumer Promotion of Prescription Drugs. Rockville, Md: Office of Medical Policy, Division of Drug Marketing, Advertising, and Communications; 2000;www.fda.gov
37. Bentley John P, Smith Mickey C, Murawski Matthew M, Banahan Benjamin F, Wilkin Noel E, Frate Dennis A, Vitell Scott J. The Inherent Burden Associated with the Consumption of Medications, presented at the 13th Annual Meeting of the American Association of Pharmaceutical Scientists, New Orleans, La, November 17, 1999.
38. Murawski Matthew M, Bentley John P. Pharmaceutical therapy-related quality of life: conceptual development. Journal of Social and Administrative Pharmacy. 2000;18:2–14
39. Strecher Victor J, Champion Victoria L, Rosenstock Irwin M. The health belief model and health behavior. In:  Gochman David S editors. Handbook of Health Behavior Research I: Personal and Social Determinants. New York: Plenum Press; 1997;p. 71–91
40. Haugtvedt Curtis P. Beyond fact or artifact: an assessment of Fishbein and Middlestadt's perspectives on attitude change processes. Journal of Consumer Psychology. 1997;6:99–106
41. Haugtvedt Curtis P, Petty Richard E, Cacioppo John T. Need for cognition and advertising: understanding the role of personality variables in consumer behavior. Journal of Consumer Psychology. 1992;1:239–260
42. Haugtvedt Curtis P, Priester JR. Conceptual and methodological issues in advertising effectiveness: an attitude strength perspective. In:  Wells W editors. Measuring Advertising Effectiveness. Erlbaum; 1997;
43. Haugtvedt Curtis P, Schumann David W, Schneier Wendy L, Warren Wendy L. Advertising repetition and variation strategies: implications for understanding attitude strength. Journal of Consumer Research. 1994;21:176–189
44. Haugtvedt Curtis P, Wegener DT. Message order effects in persuasion: an attitude strength perspective. Journal of Consumer Research. 1994;21:205–218
45. Mott David A, Schommer Jon C. Prescription Drug Insurance for the Elderly: A National Survey. Presented at the 16th Annual Meeting of the Association for Health Services Research. Chicago: Ill; June 28, 1999;
46. Mott David A, Kreling David H. The association of insurance type with costs of prescribed drugs. Inquiry. 1998;35:23–35
    • MEDLINE
47. Mott David A, Schommer Jon C, Doucette William R, Kreling David H. Agency theory and decisions within the pharmaceutical utilization system: implications for public policy. Journal of Public Policy and Marketing. 1998;17:1–8
48. Obermiller Carl, Spangenberg Eric R. Development of a scale to measure consumer skepticism toward advertising. Journal of Consumer Psychology. 1998;7:159–186
49. Kohli Ajay, Zaltman Gerald. Determinants of influence in organizational buying: a contingency approach. Journal of Marketing. 1989;53:50–65
50. Worley-Louis Marcia, Schommer Jon C, Finnegan John R. Construct identification and measure development for investigating pharmacist-patient relationships. Patient Education and Counseling. 2003;51:229–238
    • Abstract
    • Full Text
    • Full-Text PDF (149 KB)
    • CrossRef
51. Dawson Scott, Bloch Peter H, Ridgway Nancy M. Shopping motives, emotional states, and retail outcomes. Journal of Retailing. 1990;66:408–427
52. Maheswaran Durairaj, Sternthal Brian. The effects of knowledge, motivation, and type of message on ad processing and product judgments. Journal of Consumer Research. 1990;17:66–73
53. Cole Catherine A, Balasubramanian Siva K. Age differences in consumers' search for information: public policy implications. Journal of Consumer Research. 1993;20:157–169
54. Cole Catherine A, Gaeth Gary J. Cognitive and age-related differences in the ability to use nutritional information in a complex environment. Journal of Marketing Research. 1990;27:174–184
55. Doucette William R, Wiederholt Joseph B. Relationships among consumer characteristics and drug therapy process variables to consumers' meaning of prescribed medication. Journal of Pharmaceutical Marketing & Management. 1993;7:85–95
    • CrossRef
56. Doucette William R, Wiederholt Joseph B. Measurement of product meaning for prescribed medication using a Means-End Chain Model. Journal of Health Care Marketing. 1992;12:48–54
    • MEDLINE
57. Gazmararian JA, Baker DW, Williams MV, et al. Health literacy among medicare enrollees in a managed care organization. Journal of the American Medical Association. 1999;281:545–551
58. Gutman Jonathan. A Means-End Chain Model based on consumer categorization processes. Journal of Marketing. 1982;46:60–72
59. Malhotra Naresh K. Information load and consumer decision making. Journal of Consumer Research. 1982;8:419–430
60. Yoon Carolyn. Age differences in consumers' processing strategies: an investigation of moderating influences. Journal of Consumer Research. 1997;24:329–342
61. Bettman James R. An Information Processing Theory of Consumer Choice. Reading, Mass: Addison-Wesley; 1979;
62. Labor Sarah L, Schommer Jon C, Pathak Dev S. Information overload with written prescription drug information. Drug Information Journal. 1995;29:1317–1328
    • CrossRef
63. Lowrey Tina M. The effects of syntactic complexity on advertising persuasiveness. Journal of Consumer Psychology. 1998;7:187–206
64. Morrow Daniel G, Leirer Von O, Andrassy Jill M, Decker Tanke Elizabeth, Stine-Morrow Elizabeth AL. Medication instruction design: younger and older adult schemas for taking medication. Human Factors. 1996;38:556–573
    • MEDLINE
    • CrossRef
65. Petty Richard E, Cacioppo John T. Communication and Persuasion: Central and Peripheral Routes to Attitude Change. New York: Springer-Verlag; 1986;
66. Cacioppo JT, Petty RE. The need for cognition. Journal of Personality and Social Psychology. 1982;42:116–131
    • CrossRef
67. Dillman Don A. Mail and Internet Surveys: The Tailored Design Method. 2nd ed.. New York: John Wiley & Sons, Inc; 2000;